{"id":386042,"date":"2020-11-20T09:31:08","date_gmt":"2020-11-20T14:31:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=386042"},"modified":"2020-11-20T09:31:08","modified_gmt":"2020-11-20T14:31:08","slug":"nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/","title":{"rendered":"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc."},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">Nov. 20, 2020<\/span> \/PRNewswire\/ &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i)\u00a0 purchased or acquired the securities of NextCure, Inc. (&#8220;NextCure&#8221; or the &#8220;Company&#8221;) (NASDAQ: NXTC) securities between <span class=\"xn-chron\">November 5, 2019<\/span> to <span class=\"xn-chron\">July 14, 2020<\/span>; and\u00a0 (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on <span class=\"xn-chron\">November 12<\/span>, and <span class=\"xn-chron\">November 14, 2019<\/span>. The lawsuit filed in <span class=\"xn-location\">the United States<\/span> District Court for the Southern District of <span class=\"xn-location\">New York<\/span> alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.jpg\" title=\"Bernstein Liebhard LLP.  (PRNewsFoto\/Bernstein Liebhard LLP) (PRNewsfoto\/Bernstein Liebhard LLP)\" alt=\"Bernstein Liebhard LLP.  (PRNewsFoto\/Bernstein Liebhard LLP) (PRNewsfoto\/Bernstein Liebhard LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>If you <b>purchased NextCure securities, and\/or would like to discuss your legal rights and options<\/b> please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2984789-1&amp;h=2908558608&amp;u=https%3A%2F%2Fwww.bernlieb.com%2Fcases%2Fnextcureinc-nxtc-shareholder-class-action-lawsuit-stock-fraud-313%2Fapply%2F&amp;a=NXTC+Shareholder+Class+Action+Lawsuit\" rel=\"nofollow noopener noreferrer\">NXTC Shareholder Class Action Lawsuit<\/a> or contact <a target=\"_blank\" href=\"mailto:MGuarnero@bernlieb.com\" rel=\"nofollow noopener noreferrer\"><span class=\"xn-person\">Matthew E. Guarnero<\/span><\/a> toll free at <b>(877) 779-1414<\/b> or <a target=\"_blank\" href=\"mailto:MGuarnero@bernlieb.com\" rel=\"nofollow noopener noreferrer\">MGuarnero@bernlieb.com<\/a>. <\/p>\n<p>Throughout the Class Period, Defendants misled investors regarding its leading treatment candidate, NC318, which was a first-in-class immunomedicine targeting a novel immunomodulatory receptor, called Siglec-15, or S15, particularly in patients with advanced or metastatic solid tumors.<\/p>\n<p>On <span class=\"xn-chron\">July 13, 2020<\/span>, NextCure made a shocking admission.\u00a0 Specifically, in a press release entitled, &#8220;NextCure provides an Interim update of the Phase 2 Portion of the NC318 Monotherapy Phase 1\/2 Trial and Announces Departure Chief Medical Officer,&#8221; NextCure announced that the Company was no longer planning to &#8220;advance the nonsmall cell lung cancer (NSCLC) and ovarian cancer cohorts in the stage 2 portion of the Simon 2-stage trial,&#8221; citing &#8220;clinical response data&#8221; and &#8220;current enrollment criteria.&#8221; The <span class=\"xn-chron\">July 13, 2020<\/span> announcement continued, stating, in relevant part, &#8220;The analysis of biomarker data for these cohorts has been delayed and is not yet complete.\u00a0 The company will evaluate whether to pursue additional monotherapy studies in NSCLC and ovarian cancer after a review of that information.&#8221;<\/p>\n<p>On this news, NextCure&#8217;s shares, which had closed at <span class=\"xn-money\">$17.88<\/span> per share on <span class=\"xn-chron\">July 10, 2020<\/span>, dropped over 54% the next trading day to close at <span class=\"xn-money\">$8.15<\/span> per share on <span class=\"xn-chron\">July 13, 2020<\/span> on unusually high trading volume.<\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court no later than <span class=\"xn-chron\">November 20, 2020<\/span>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn&#8217;t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.<\/p>\n<p>If you <b>purchased NextCure securities, and\/or would like to discuss your legal rights and options<\/b> please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2984789-1&amp;h=343669114&amp;u=https%3A%2F%2Fwww.bernlieb.com%2Fcases%2Fnextcureinc-nxtc-shareholder-class-action-lawsuit-stock-fraud-313%2Fapply%2F&amp;a=https%3A%2F%2Fwww.bernlieb.com%2Fcases%2Fnextcureinc-nxtc-shareholder-class-action-lawsuit-stock-fraud-313%2Fapply%2F\" rel=\"nofollow noopener noreferrer\">https:\/\/www.bernlieb.com\/cases\/nextcureinc-nxtc-shareholder-class-action-lawsuit-stock-fraud-313\/apply\/<\/a> contact <a target=\"_blank\" href=\"mailto:MGuarnero@bernlieb.com\" rel=\"nofollow noopener noreferrer\"><span class=\"xn-person\">Matthew E. Guarnero<\/span><\/a> toll free at <b>(877) 779-1414<\/b> or <a target=\"_blank\" href=\"mailto:MGuarnero@bernlieb.com\" rel=\"nofollow noopener noreferrer\">MGuarnero@bernlieb.com<\/a> . <\/p>\n<p>Since 1993, Bernstein Liebhard LLP has recovered over <span class=\"xn-money\">$3.5 billion<\/span> for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to\u00a0<i>The National Law Journal&#8217;s<\/i>\u00a0&#8220;Plaintiffs&#8217; Hot List&#8221; thirteen times and listed in\u00a0<i>The Legal 500\u00a0<\/i>for ten consecutive years.<\/p>\n<p>ATTORNEY ADVERTISING. \u00a9 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, <span class=\"xn-location\">New York, New York<\/span> 10016, (212) 779-1414. The lawyer responsible for this advertisement in the <span class=\"xn-location\">State of Connecticut<\/span> is Michael S. Bigin.\u00a0 Prior results do not guarantee or predict a similar outcome with respect to any future matter.<\/p>\n<p>Contact Information: <br \/><a target=\"_blank\" href=\"mailto:MGuarnero@bernlieb.com\" rel=\"nofollow noopener noreferrer\"><span class=\"xn-person\">Matthew E. Guarnero<\/span><\/a><br \/>Bernstein Liebhard LLP<br \/><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2984789-1&amp;h=576867881&amp;u=https%3A%2F%2Fwww.bernlieb.com%2F&amp;a=https%3A%2F%2Fwww.bernlieb.com\" rel=\"nofollow noopener noreferrer\">https:\/\/www.bernlieb.com<\/a><br \/>(877) 779-1414<br \/><a target=\"_blank\" href=\"mailto:MGuarnero@bernlieb.com\" rel=\"nofollow noopener noreferrer\">MGuarnero@bernlieb.com<\/a><\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC94829&amp;sd=2020-11-20\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-301177836.html\">http:\/\/www.prnewswire.com\/news-releases\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-301177836.html<\/a><\/p>\n<p>SOURCE  Bernstein Liebhard LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC94829&amp;Transmission_Id=202011200928PR_NEWS_USPR_____DC94829&amp;DateId=20201120\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, Nov. 20, 2020 \/PRNewswire\/ &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i)\u00a0 purchased or acquired the securities of NextCure, Inc. (&#8220;NextCure&#8221; or the &#8220;Company&#8221;) (NASDAQ: NXTC) securities between November 5, 2019 to July 14, 2020; and\u00a0 (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on November 12, and November 14, 2019. The lawsuit filed in the United States District Court for the Southern District of New York &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-386042","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Nov. 20, 2020 \/PRNewswire\/ &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i)\u00a0 purchased or acquired the securities of NextCure, Inc. (&#8220;NextCure&#8221; or the &#8220;Company&#8221;) (NASDAQ: NXTC) securities between November 5, 2019 to July 14, 2020; and\u00a0 (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on November 12, and November 14, 2019. The lawsuit filed in the United States District Court for the Southern District of New York &hellip; Continue reading &quot;NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-20T14:31:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.\",\"datePublished\":\"2020-11-20T14:31:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/\"},\"wordCount\":641,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616919\\\/Bernstein_Liebhard_LLP_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/\",\"name\":\"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616919\\\/Bernstein_Liebhard_LLP_Logo.jpg\",\"datePublished\":\"2020-11-20T14:31:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616919\\\/Bernstein_Liebhard_LLP_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/616919\\\/Bernstein_Liebhard_LLP_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/","og_locale":"en_US","og_type":"article","og_title":"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk","og_description":"PR Newswire NEW YORK, Nov. 20, 2020 \/PRNewswire\/ &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i)\u00a0 purchased or acquired the securities of NextCure, Inc. (&#8220;NextCure&#8221; or the &#8220;Company&#8221;) (NASDAQ: NXTC) securities between November 5, 2019 to July 14, 2020; and\u00a0 (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on November 12, and November 14, 2019. The lawsuit filed in the United States District Court for the Southern District of New York &hellip; Continue reading \"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-20T14:31:08+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.","datePublished":"2020-11-20T14:31:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/"},"wordCount":641,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/","name":"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.jpg","datePublished":"2020-11-20T14:31:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/616919\/Bernstein_Liebhard_LLP_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-class-action-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=386042"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386042\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=386042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=386042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=386042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}